KRAS and familial pancreatic carcinoma: The phosphorylation of selected kinases of MIA PaCa-2 and Aspc1 pancreatic cancer cell lines were compared to BH1362 NSCLC cell line carrying a KRAS G12C mutation for controls and cells pretreated with BAY-293 in Western Blot arrays.